Agreed, this really isn't much of an announcement trout. Not...

Agreed, this really isn't much of an announcement trout.

Not only have these clowns demonstrated again that they don't have the ability to write anything that makes any sense at all any more, but the formulation that just got approved here (for these two and all the other mentioned territories) was the same one that Pfizer didn't want when they reviewed it previously. This isn't the hydrotropes patent and therefore isn't very important information.

Still nothing to see here, although Mr small caps has a really, really, really good feeling about Anagrelide which is............... err ............great.